One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
One Biosciences's investors include Sofinnova Partners, Redmile Group, Kima Ventures, Invus, Blast. Club.
One Biosciences is headquartered in Paris, France.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
One Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"One Biosciences — Funding & Investors." VCBacked, June 18, 2026, https://www.vcbacked.co/company/one-biosciences. Accessed July 19, 2026.
VCBacked. (2026). One Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/one-biosciences
{{cite web |title=One Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/one-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated